DMSO cryopreservation is the method of choice to preserve cells for droplet-based single-cell RNA sequencing.
Combining single-cell RNA sequencing (scRNA-seq) with upstream cell preservation procedures equivalent to cryopreservation or methanol fixation has just lately turn into extra frequent.
By separating cell dealing with and preparation, from downstream library era, scRNA-seq workflows are extra versatile and manageable. However, the inherent transcriptomic adjustments related to cell preservation and the way they might bias additional downstream evaluation stay unknown.
Here, we current a side-by-side droplet-based scRNA-seq evaluation, evaluating the gold normal – contemporary cells – to three completely different cell preservation workflows: dimethyl sulfoxide primarily based cryopreservation, methanol fixation and CellCover reagent.
Cryopreservation proved to be the most sturdy protocol, maximizing each cell integrity and low background ambient RNA. Importantly, gene expression profiles from contemporary cells correlated most with these of cryopreserved cells. Such similarities had been constantly noticed throughout the examined cell strains (R ≥ 0.97), monocyte-derived macrophages (R = 0.97) and immune cells (R = 0.99).
In distinction, each methanol fixation and CellCover preservation confirmed an elevated ambient RNA background and an total decrease gene expression correlation to contemporary cells.
Thus, our outcomes reveal the superiority of cryopreservation over different cell preservation strategies. We anticipate our comparative research to present single-cell omics researchers invaluable assist when integrating cell preservation into their scRNA-seq research.
Beyond fertility preservation: function of the oncofertility unit in the reproductive and gynecological follow-up of younger most cancers sufferers.
Are there causes that inspire younger most cancers survivors to ask for follow-up visits at an oncofertility unit?Cancer survivors request oncofertility follow-up visits for the administration of treatment-related unwanted side effects or ovarian reserve analysis, even when not (or not but) wishing for a being pregnant.
Personalised oncofertility counselling earlier than gonadotoxic therapies is thought-about normal of care for younger ladies with newly recognized most cancers.
However, the long-term follow-up of these sufferers in an oncofertility unit is not described in the literature aside from for the use of cryopreserved materials.
We retrospectively examined charges and causes for the first follow-up visits of 154 consecutive younger feminine most cancers sufferers (age vary: 18-40 years) who underwent a pre-treatment session between January 2012 and June 2017.
Demographic and medical information had been collected, in addition to details about the chosen fertility preservation method, if any.Rates and causes for follow-up visits had been collected and expressed as percentages. Different causes had been examined in the complete cohort and stratified for kind of malignancy.
Possible predictive elements for return to the follow-up go to (age, nulliparity, presence of a associate, neoplasm, having cryopreserved materials) had been investigated by way of logistic regression.Out of 154 sufferers, 74 returned to the oncofertility unit (48.1%) for a follow-up go to. The first go to was requested largely at the finish of anticancer therapies (51.3% versus 40.5% throughout therapies and eight.1% after most cancers relapse).
Among these sufferers, solely 10.8% returned for the first time as a result of they had been actively needing a being pregnant. For the others, the most typical causes for consultations had been administration of gynecological opposed results of therapies (29.7%) and analysis of ovarian reserve not linked to a right away want for a being pregnant (39.2%). Other sufferers requested for contraception (4.1%), menopause counselling (5.4%), or new fertility preservation counselling as a result of of most cancers relapse (10.8%). None of the examined elements had been considerably predictive of return to the oncofertility unit.
These findings signify the expertise of a single centre. An extended period of follow-up could be wanted to present extra exact info on this regard.The function of an oncofertility unit shouldn’t be restricted to proposing fertility preservation procedures.
In the administration of younger grownup most cancers sufferers, the reproductive medical specialist must be thought-about a key determine not solely earlier than but in addition throughout and after anticancer remedies to discover salient facets of gynecological and reproductive well being.
This analysis didn’t obtain any particular funding. M.L. served as a advisor for Teva and acquired honoraria from Theramex outdoors the submitted work. The different authors declare no battle of curiosity.N.A.